Wegovy 2.4 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FFFT5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,225
Award facts
- Contract value 100% obligated
- $18,225.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,225.26 to AmerisourceBergen Drug Corp for Wegovy 2.4 mg/0.75 ml pens on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of delivery orders with the Defense Logistics Agency. The company's federal contract awards demonstrate capability across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order for Wegovy—a GLP-1 receptor agonist used for weight management—reflects the company's ongoing role supplying pharmaceutical products to support military and veteran healthcare systems. As a non-set-aside competitive award, this transaction exemplifies AmerisourceBergen's continued participation in the DLA's pharmaceutical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DB25FFFT5?
SPE2DB25FFFT5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FFFT5 worth?
The government has obligated $18,225 on SPE2DB25FFFT5.
Is contract SPE2DB25FFFT5 an order under another contract?
Yes. SPE2DB25FFFT5 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFFT5 competed?
The extent of competition for SPE2DB25FFFT5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award